Collecting Duct Renal Cell Carcinoma Found to Involve the Collecting System During Partial Nephrectomy: A Case Report
Main Article Content
Keywords
collecting duct carcinoma, renal cell carcinoma, partial nephrectomy, collecting system
Abstract
Collecting duct carcinoma (CDC) is a rare and aggressive form of renal cell carcinoma (RCC) arising from the principal cells of the collecting duct. One third of cases present with metastatic disease, but many present in a manner similar to conventional RCC or urothelial carcinoma (UC). We discuss a case of CDC which presented as a small mass at the cortico-medullary junction, and was discovered at robotic partial nephrectomy (RPN) to be grossly involving the collecting system. A 62-year-old man presented with a small renal mass suspicious for RCC, which was found on computed tomography (CT) after an episode of gross hematuria. After thorough workup, RPN was attempted; however, intraoperatively the mass was found to be involving the collecting system. Radical nephroureterectomy was performed, and the pathology report revealed CDC. CDC is a rare and aggressive form of RCC. While many cases are metastatic at diagnosis, most patients present with the incidental finding of a small renal mass. There are no reports of a CDC involving the collecting system at RPN after negative ureteroscopy preoperatively. The adjuvant therapeutic options for CDC are limited, and long term survival is poor.
References
2. Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, Igarashi T. Japanese Society of Renal Cancer. Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J Urol. 2006;176(1):40-3. http://dx.doi.org/10.1016/S0022-5347(06)00502-7
3. Kwon KA et al. Clinical features and treatment of collecting duct carcinoma of the kidney from the korean cancer study group genitourinary and gynecology cancer committee. Cancer Res Treat. 2014;46(2):141-7. http://dx.doi.org/10.4143/crt.2014.46.2.141
4. Gupta R et al. Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. Am J Surg Pathol. 2012;36(9):1265-78. http://dx.doi.org/10.1097/PAS.0b013e3182635954
5. Xu Q, Cao Q, Liu N, Fang Z, Ye Z, Peng T. Renal collecting duct carcinoma with extensive coagulative necrosis mimicking anemic infarct: report of a case and the literature review. Diagn Pathol. 2013;8:119. http://dx.doi.org/10.1186/1746-1596-8-119
6. Yasuda E, Kuwabara H, Shibayama Y. Collecting duct renal cell carcinoma with the syndrome of inappropriate antidiuresis: an autopsy case report. Indian J Pathol Microbiol. 2013;56(1):43-6. http://dx.doi.org/10.4103/0377-4929.116148
7. Sugiura S, Makiyama K, Nakaigawa N, Yao M, Kubota Y, Oshiro H. Collecting duct carcinoma producing granulocyte-colony-stimulating factor (G-CSF). Int J Urol. 2007;14(6):555-7. http://dx.doi.org/10.1111/j.1442-2042.2006.01711.x
8. Srigley JR et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol. 2013;37(10):1469-89. http://dx.doi.org/10.1097/PAS.0b013e318299f2d1
9. Pepek JM, Johnstone PA, Jani AB. Influence of demographic factors on outcome of collecting duct carcinoma: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Clin Genitourin Cancer. 2009;7(2):E24-7. http://dx.doi.org/10.3816/CGC.2009.n.017
10. Gonzalez-Roibon N, Albadine R, Sharma R, Faraj SF, Illei PB, Argani P, Ertoy D, Allaf ME, Netto GJ. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas. Hum Pathol. 2013;44(12):2651-7. http://dx.doi.org/10.1016/j.humpath.2013.07.006.
11. Becker F et al. Collecting duct carcinomas represent a unique tumor entity based on genetic alterations. PLoS One. 2013;8(10):e78137. http://dx.doi.org/10.1371/journal.pone.0078137
12. Yoon SK, Nam KJ, Rha SH, Kim JK, Cho KS, Kim B, Kim KH, Kim KA. Collecting duct carcinoma of the kidney: CT and pathologic correlation. Eur J Radiol. 2006;57(3):453-60. http://dx.doi.org/10.1016/j.ejrad.2005.09.009
13. Mimura A, Sakuma T, Furuta M, Tanigawa N, Takamizu R, Kawano K. Sarcomatoid collecting duct carcinoma of kidney diagnosed with urine and renal pelvic lavage cytology. Diagn Cytopathol. 2010;38(8):603-6.
14. Dason S, Allard C, Sheridan-Jonah A, Gill J, Jamshaid H, Aziz T, Kajal B, Kapoor A. Management of renal collecting duct carcinoma: a systematic review and the McMaster experience. Curr Oncol. 2013;20(3):e223-32. http://dx.doi.org/ 10.3747/co.20.1230.
15. Oudard S et al. Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Genitales) study. J Urol. 2007;177(5):1698-702. http://dx.doi.org/10.1016/j.juro.2007.01.063
16. Motzer RJ, Bacik J, Mariani T, Russo P, Mazumdar M, Reuter V. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol. 2002;20(9):2376-81. http://dx.doi.org/10.1200/JCO.2002.11.123
17. Procopio G, Verzoni E, Iacovelli R, Colecchia M, Torelli T, Mariani L. Is there a role for targeted therapies in the collecting ducts of Bellini carcinoma? Efficacy data from a retrospective analysis of 7 cases. Clin Exp Nephrol. 2012;16(3):464-7. http://dx.doi.org/10.1007/s10157-012-0589-3
18. Miyake H, Haraguchi T, Takenaka A, Fujisawa M. Metastatic collecting duct carcinoma of the kidney responded to sunitinib. Int J Clin Oncol. 2011;16(2):153-5. http://dx.doi.org/10.1007/s10147-010-0116-z
19. Staehler M, Haseke N, Schoppler G, Stadler T, Karl A, Siebels M, Ihrler S, Stief CG. Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase-inhibition with sunitinib. Eur J Med Res. 2008;13(11):531-5.
20. Ansari J, Fatima A, Chaudhri S, Bhatt RI, Wallace M, James ND. Sorafenib induces therapeutic response in a patient with metastatic collecting duct carcinoma of kidney. Onkologie. 2009;32(1-2):44-6. http://dx.doi.org/10.1159/000183736
